InflaRx N.V.(IFRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IFRX InflaRx N.V.

休市中 07-26 16:00:00 EDT

1.53

+0.00

0.00%

盘后1.53

+0.000.00%

16:00 EDT

最高1.57	最低1.46	成交量8.77万
今开1.53	昨收1.53	日振幅7.19%
总市值9,009万	流通市值7,471万	总股本5,888万
成交额13.32万	换手率0.18%	流通股本4,883万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IFRX","market":"US","secType":"STK","nameCN":"InflaRx N.V.","latestPrice":1.53,"timestamp":1722024000000,"preClose":1.53,"halted":0,"volume":87651,"hourTrading":{"tag":"盘后","latestPrice":1.53,"preClose":1.53,"latestTime":"16:00 EDT","volume":5,"amount":7.65,"timestamp":1722024001267},"delay":0,"floatShares":48826874,"shares":58883272,"eps":-0.760986,"marketStatus":"休市中","marketStatusCode":7,"change":0,"latestTime":"07-26 16:00:00 EDT","open":1.53,"high":1.57,"low":1.46,"amount":133215.697437,"amplitude":0.071895,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.760986,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1722240000000},"adr":0,"listingDate":1510117200000,"adjPreClose":1.53,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.6,"preClose":1.53,"latestTime":"09:06 EDT","volume":5,"amount":8,"timestamp":1721999208710},"postHourTrading":{"tag":"盘后","latestPrice":1.53,"preClose":1.53,"latestTime":"16:00 EDT","volume":5,"amount":7.65,"timestamp":1722024001267},"volumeRatio":1.9487700626593307,"impliedVol":1.388,"impliedVolPercentile":0.8373},"requestUrl":"/m/hq/s/IFRX","defaultTab":"news","newsList":[{"id":"2454374878","title":"Inflarx N.V.盘中异动 股价大涨5.17%报1.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454374878","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454374878?lang=zh_cn&edition=full","pubTime":"2024-07-25 03:57","pubTimestamp":1721851072,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日03时57分，Inflarx N.V.股票出现异动，股价快速拉升5.17%。截至发稿，该股报1.53美元/股，成交量4.4558万股，换手率0.08%，振幅4.14%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.49%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407250357529681fe90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407250357529681fe90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","IFRX","BK4007","BK4139"],"gpt_icon":1},{"id":"2453706241","title":"Inflarx N.V.盘中异动 临近收盘急速下挫5.23%报1.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453706241","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453706241?lang=zh_cn&edition=full","pubTime":"2024-07-24 04:01","pubTimestamp":1721764880,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日04时01分，Inflarx N.V.股票出现异动，股价急速下挫5.23%。截至发稿，该股报1.45美元/股，成交量4.6629万股，换手率0.08%，振幅7.84%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.32%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724040120af93b33a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724040120af93b33a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2452288342","title":"Inflarx N.V.盘中异动 大幅跳水5.03%报1.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452288342","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452288342?lang=zh_cn&edition=full","pubTime":"2024-07-20 03:11","pubTimestamp":1721416308,"startTime":"0","endTime":"0","summary":"北京时间2024年07月20日03时11分，Inflarx N.V.股票出现波动，股价急速下跌5.03%。截至发稿，该股报1.51美元/股，成交量3.0336万股，换手率0.05%，振幅4.92%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.01%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240720031149aefa8d67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240720031149aefa8d67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","IFRX","VRPX"],"gpt_icon":0},{"id":"2452438315","title":"Inflarx N.V.盘中异动 股价大涨5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452438315","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452438315?lang=zh_cn&edition=full","pubTime":"2024-07-18 22:33","pubTimestamp":1721313215,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日22时33分，Inflarx N.V.股票出现波动，股价快速上涨5.60%。截至发稿，该股报1.68美元/股，成交量2598股，换手率0.00%，振幅5.35%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.40%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718223335aefa58e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718223335aefa58e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IFRX"],"gpt_icon":0},{"id":"2452194596","title":"Inflarx N.V.盘中异动 临近收盘快速下跌5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452194596","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452194596?lang=zh_cn&edition=full","pubTime":"2024-07-18 04:01","pubTimestamp":1721246464,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日04时01分，Inflarx N.V.股票出现异动，股价快速下挫5.36%。截至发稿，该股报1.59美元/股，成交量5.6572万股，换手率0.10%，振幅4.76%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为2.21%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407180401049681dbd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407180401049681dbd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2450753571","title":"Inflarx N.V.盘中异动 快速上涨6.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450753571","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450753571?lang=zh_cn&edition=full","pubTime":"2024-07-12 21:31","pubTimestamp":1720791112,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日21时31分，Inflarx N.V.股票出现波动，股价大幅上涨6.10%。截至发稿，该股报1.74美元/股，成交量3.6701万股，换手率0.06%，振幅0.00%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.61%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407122131529f3c013c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407122131529f3c013c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IFRX"],"gpt_icon":0},{"id":"2450459842","title":"Inflarx N.V.盘中异动 下午盘股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450459842","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450459842?lang=zh_cn&edition=full","pubTime":"2024-07-11 03:03","pubTimestamp":1720638190,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日03时03分，Inflarx N.V.股票出现异动，股价大幅跳水5.09%。截至发稿，该股报1.59美元/股，成交量3.0788万股，换手率0.05%，振幅5.99%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为1.31%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711030310aef902f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711030310aef902f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2450215840","title":"Inflarx N.V.盘中异动 早盘急速拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450215840","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450215840?lang=zh_cn&edition=full","pubTime":"2024-07-09 22:58","pubTimestamp":1720537087,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日22时58分，Inflarx N.V.股票出现波动，股价大幅拉升5.10%。截至发稿，该股报1.65美元/股，成交量2.9218万股，换手率0.05%，振幅7.64%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.53%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709225807941f5752&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709225807941f5752&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139","LGVN"],"gpt_icon":0},{"id":"2449703031","title":"Inflarx N.V.盘中异动 早盘股价大跌6.71%报1.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449703031","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449703031?lang=zh_cn&edition=full","pubTime":"2024-07-08 21:31","pubTimestamp":1720445514,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日21时31分，Inflarx N.V.股票出现异动，股价快速跳水6.71%。截至发稿，该股报1.53美元/股，成交量1.3771万股，换手率0.02%，振幅0.00%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.16%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708213154941f4ea5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708213154941f4ea5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2449857216","title":"Inflarx N.V.盘中异动 下午盘股价大跌5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449857216","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449857216?lang=zh_cn&edition=full","pubTime":"2024-07-06 02:24","pubTimestamp":1720203845,"startTime":"0","endTime":"0","summary":"北京时间2024年07月06日02时24分，Inflarx N.V.股票出现波动，股价快速下跌5.52%。截至发稿，该股报1.54美元/股，成交量4.3573万股，换手率0.07%，振幅6.50%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为1.01%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407060224059681a338&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407060224059681a338&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2448482103","title":"Inflarx N.V.盘中异动 快速下挫5.78%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448482103","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448482103?lang=zh_cn&edition=full","pubTime":"2024-07-03 23:31","pubTimestamp":1720020716,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日23时31分，Inflarx N.V.股票出现波动，股价急速下挫5.78%。截至发稿，该股报1.63美元/股，成交量2.3086万股，换手率0.04%，振幅5.20%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为2.13%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703233156968193dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703233156968193dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IFRX"],"gpt_icon":0},{"id":"2448143909","title":"Inflarx N.V.盘中异动 股价大跌6.32%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448143909","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448143909?lang=zh_cn&edition=full","pubTime":"2024-07-01 22:52","pubTimestamp":1719845525,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日22时52分，Inflarx N.V.股票出现波动，股价急速下挫6.32%。截至发稿，该股报1.63美元/股，成交量3.4369万股，换手率0.06%，振幅6.66%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.56%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407012252069681873e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407012252069681873e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2446564842","title":"Inflarx N.V.盘中异动 下午盘股价大涨5.00%报1.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446564842","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446564842?lang=zh_cn&edition=full","pubTime":"2024-06-28 02:39","pubTimestamp":1719513561,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日02时39分，Inflarx N.V.股票出现异动，股价快速拉升5.00%。截至发稿，该股报1.68美元/股，成交量10.1517万股，换手率0.17%，振幅7.50%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.59%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628023921941f1ddb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628023921941f1ddb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IFRX"],"gpt_icon":0},{"id":"2446418798","title":"Inflarx N.V.盘中异动 早盘股价大涨5.18%报1.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446418798","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446418798?lang=zh_cn&edition=full","pubTime":"2024-06-25 21:39","pubTimestamp":1719322788,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日21时39分，Inflarx N.V.股票出现波动，股价大幅拉升5.18%。截至发稿，该股报1.76美元/股，成交量1.4204万股，换手率0.02%，振幅0.01%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.76%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625213949aef68721&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625213949aef68721&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2445074403","title":"Inflarx N.V.盘中异动 早盘股价大涨5.19%报1.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445074403","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445074403?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:36","pubTimestamp":1719236212,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时36分，Inflarx N.V.股票出现异动，股价大幅拉升5.19%。截至发稿，该股报1.62美元/股，成交量1.9733万股，换手率0.03%，振幅6.49%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.65%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624213652af8eeb96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624213652af8eeb96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IFRX"],"gpt_icon":0},{"id":"2444248374","title":"Inflarx N.V.盘中异动 早盘股价大涨5.03%报1.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444248374","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444248374?lang=zh_cn&edition=full","pubTime":"2024-06-20 22:20","pubTimestamp":1718893218,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日22时20分，Inflarx N.V.股票出现波动，股价快速拉升5.03%。截至发稿，该股报1.53美元/股，成交量5442股，换手率0.01%，振幅3.42%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.13%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620222019aef5dbc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620222019aef5dbc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2444193127","title":"Inflarx N.V.盘中异动 早盘大幅下挫5.13%报1.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444193127","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444193127?lang=zh_cn&edition=full","pubTime":"2024-06-17 22:26","pubTimestamp":1718634418,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日22时26分，Inflarx N.V.股票出现异动，股价大幅跳水5.13%。截至发稿，该股报1.48美元/股，成交量1360股，换手率0.00%，振幅0.00%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.26%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061722265896814a65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061722265896814a65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2443016526","title":"Inflarx N.V.盘中异动 下午盘急速上涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443016526","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443016526?lang=zh_cn&edition=full","pubTime":"2024-06-15 02:47","pubTimestamp":1718390822,"startTime":"0","endTime":"0","summary":"北京时间2024年06月15日02时47分，Inflarx N.V.股票出现波动，股价大幅上涨5.26%。截至发稿，该股报1.60美元/股，成交量7.29万股，换手率0.12%，振幅7.89%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.14%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615024702968145d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615024702968145d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IFRX"],"gpt_icon":0},{"id":"2443849116","title":"Inflarx N.V.盘中异动 大幅下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443849116","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443849116?lang=zh_cn&edition=full","pubTime":"2024-06-13 22:20","pubTimestamp":1718288446,"startTime":"0","endTime":"0","summary":"北京时间2024年06月13日22时20分，Inflarx N.V.股票出现波动，股价大幅跳水5.03%。截至发稿，该股报1.51美元/股，成交量5.6912万股，换手率0.10%，振幅2.52%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.36%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240613222047af8d6f3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240613222047af8d6f3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGVN","BK4139","IFRX"],"gpt_icon":0},{"id":"2442631465","title":"Inflarx N.V.盘中异动 快速下挫5.70%报1.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442631465","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442631465?lang=zh_cn&edition=full","pubTime":"2024-06-12 00:54","pubTimestamp":1718124886,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日00时54分，Inflarx N.V.股票出现波动，股价大幅跳水5.70%。截至发稿，该股报1.49美元/股，成交量8260股，换手率0.01%，振幅2.85%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.20%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612005447941edc9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612005447941edc9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inflarx.com","stockEarnings":[{"period":"1week","weight":0.0066},{"period":"1month","weight":-0.0438},{"period":"3month","weight":0.1504},{"period":"6month","weight":-0.0065},{"period":"1year","weight":-0.6241},{"period":"ytd","weight":-0.0613}],"compareEarnings":[{"period":"1week","weight":-0.0083},{"period":"1month","weight":-0.002},{"period":"3month","weight":0.0712},{"period":"6month","weight":0.117},{"period":"1year","weight":0.2032},{"period":"ytd","weight":0.1454}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"InflaRx N.V.于2017年6月根据荷兰法律成立，根据公司重组的条款，该公司是一家InflaRx GmbH的控股的公司。该公司是一家临床阶段的生物制药公司，专注于应用其独有的反C5a技术来发现和开发一种名为C5a的补充激活因子的一级、有效和特异性抑制剂。C5a是一种强大的炎症介质，涉及多种自身免疫和其他炎症疾病的进展。","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.090583},{"month":2,"riseRate":0.571429,"avgChangeRate":0.006427},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.068353},{"month":4,"riseRate":0.571429,"avgChangeRate":0.389384},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.049969},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.19704},{"month":7,"riseRate":0.285714,"avgChangeRate":0.081211},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.053477},{"month":9,"riseRate":0.5,"avgChangeRate":-0.032601},{"month":10,"riseRate":0.333333,"avgChangeRate":0.016141},{"month":11,"riseRate":0.5,"avgChangeRate":0.042008},{"month":12,"riseRate":0.714286,"avgChangeRate":0.137243}],"exchange":"NASDAQ","name":"InflaRx N.V.","nameEN":"InflaRx N.V."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"InflaRx N.V.(IFRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供InflaRx N.V.(IFRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"InflaRx N.V.,IFRX,InflaRx N.V.股票,InflaRx N.V.股票老虎,InflaRx N.V.股票老虎国际,InflaRx N.V.行情,InflaRx N.V.股票行情,InflaRx N.V.股价,InflaRx N.V.股市,InflaRx N.V.股票价格,InflaRx N.V.股票交易,InflaRx N.V.股票购买,InflaRx N.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"InflaRx N.V.(IFRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供InflaRx N.V.(IFRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}